ليست عنوان مقالات لاتين Anesthesia Considerations in Surgical Deep Brain Stimulation for Tourette Syndrome Management: a Case Report Angiotensin-converting enzyme inhibitors as a cause of unilateral tongue angioedema in a 68-year-old woman

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Anesthesia Considerations in Surgical Deep Brain Stimulation for Tourette Syndrome Management: a Case Report

2

Anesthesia Depth Measurement with Bispectral Index Monitoring during Minor Surgery among Children With and Without Cerebral Palsy

3

Anesthesia Experience for Open Gastrostomy With Ultrasound-Guided Unilateral Subcostal Transversus Abdominis Plane Block in a High Risk Elderly Patient: A Case Report

4

Anesthesia Experience In a Child Affected By Congenital Cystic Adenomatoid Malformation And Retinopathy Of Prematurity For Eye Laser Procedure

5

Anesthesia facilitation of external cephalic version: A meta-analysis

6

ANESTHESIA FOR A PATIENT WITH WILSON’S DISEASE - A Case Report -

7

ANESTHESIA FOR ARTHROSCOPIC SHOULDER SURGERY IN THE BEACH CHAIR POSITION: MONITORING OF CEREBRAL OXYGENATION USING COMBINED BISPECTRAL INDEX AND NEAR-INFRARED SPECTROSCOPY

8

ANESTHESIA FOR CESAREAN SECTION IN A PATIENT WITH A TRANSPOSITION OF GREAT ARTERIES - Case Report -

9

Anesthesia for cesarean section in pregnancies complicated by placenta previa

10

ANESTHESIA FOR CESARIAN SECTION IN PREGNANT WOMAN WITH ACUTE INTERMITTENT PORPHYRIA AND HYPOTHYROIDISM

11

Anesthesia for coronary artery bypass grafting with hypothermic cardiopulmonary bypass in a patient with a A2B negative Blood Group

12

Anesthesia for cutaneous laser therapy

13

Anesthesia for dermatologic procedures and their complications

14

Anesthesia for gingivectomy and dental extractions in a child with I-Cell Disease

15

Anesthesia for herniotomy in Schwartz–Jampel syndrome

16

ANESTHESIA FOR LAPAROSCOPIC CHOLECYSTECTOMY: COMPARATIVE EVALUATION OF - Desflurane/Sevoflurane vs. Propofol -

17

ANESTHESIA FOR NELSON’S SYNDROME - Case Report -

18

Anesthesia for Patients With Liver Disease

19

Anesthesia for Pediatric Lung Transplantation: Case Presentation and Review of the Literature

20

ANESTHESIA FOR THIRD VENTRICULOSTOMY - A Report of 128 Cases -

21

ANESTHESIA FOR THORACOSCOPIC THYMECTOMY: MODIFIED NON-MUSCLE RELAXANT TECHNIQUE - Case Reports -

22

ANESTHESIA FOR THYMECTOMY IN MYASTHENIA GRAVIS - A report of 115 cases -

23

Anesthesia for Trans Sternal Thymectomy: Modified Non-muscle Relaxant Technique

24

Anesthesia in a pediatric patient with Xeroderma pigmentousoma: A case report

25

Anesthesia in an adult patient with patent ductus arteriosus

26

Anesthesia in multiple sclerosis and obstructive sleep apnea: case report and literature review

27

Anesthesia in peripartum cardiomyopathy

28

Anesthesia Inhibits Interferon-Induced Natural Killer Cell Cytotoxicity via Induction of CD8+ Suppressor Cells

29

Anesthesia Issues and Challenges: An African Perspective

30

Anesthesia Length in Ultra Rapid Opioid Detoxification

31

Anesthesia Management for the Patient with Chronic Decompensated Heart Failure and Low Cardiac Output Undergoing CABG with Advanced Cardiac Monitoring: A Case Report

32

Anesthesia Management in a Case of Apert Syndrome

33

Anesthesia Management in a Child with Letterer Siwe Disease

34

Anesthesia Management in a Hypertrophic Cardiomyopathy Patient with Brain Tumor: A Case Report

35

Anesthesia Management in a Patient with Kabuki Syndrome

36

Anesthesia Management in a Patient with Patau Syndrome Who Underwent Bilateral Vitrectomy

37

Anesthesia Management in Achondroplasia: A Case Report

38

Anesthesia Management in an 11-Month Old Infant with Pompe Disease

39

Anesthesia Management in an Edentulous Patient with Huge Parotid Tumour: Case Report

40

Anesthesia Management in Patient with Plasminogen Deficiency for Cesarean Section (C/S): A Case Report

41

Anesthesia Management in Rare Case: Cutis Laxa Syndrome

42

Anesthesia Management in Redo Mitral Valve Replacement Surgery in a Patient with a Rare Blood Group: A Case Report

43

ANESTHESIA MANAGEMENT OF A JEHOVAH’S WITNESS PATIENT WITH PHEOCHROMOCYTOMA UNDERGOING OFF PUMP CORONARY ARTERY BYPASS GRAFT SURGERY - A Case Report -

44

Anesthesia Management of a Patient with Lumbar Spinal Stenosis and Tracheal Stenting

45

Anesthesia Management of a Patient with Papillon-Lefevre Syndrome: A Case Report

46

Anesthesia Management of Electroconvulsive Therapy at the Late of Pregnancy: A Case Report

47

Anesthesia Management of Vitrectomy in a Patient with Sturge-Weber Syndrome

48

Anesthesia Methods in Pregnant Women: A Review Study

49

Anesthesia of juvenile Persian sturgeon, Acipenser persicus; Borodin 1897, by peppermint, Mentha piperita, extract – Anesthetic efficacy, stress response and behavior

50

ANESTHESIA OUTCOME PREDICTION

51

Anesthesia Preoperative Clinic Evaluation of Obstructive Sleep Apnea Using Nasal Fiberoptic Videoendoscopy: A Pilot Study Comparison with Polysomnography

52

Anesthesia Preoperative Clinic Referral for Elevated Hba1c Reduces Complication Rate in Diabetic Patients Undergoing Total Joint Arthroplasty

53

ANESTHESIA PROTOCOL FOR LIVER TRANSPLANT

54

Anesthesia Related Complications of Gastrointestinal Endoscopies; A Retrospective Descriptive Study

55

Anesthesia Teaching for Undergraduates; Bringing the Operating Theatre to the Simulation Lab: A Pilot Study

56

Anesthesia technique and serum cytokine concentrations in the elective cesarean section

57

Anesthesia Techniques in In-Office Aesthetic Surgery: A Narrative Review

58

Anesthesia Type and Short-Term Outcomes in Open Treatment of Hand Fractures

59

ANESTHESIA WITH ETOMIDATE AND REMIFENTANIL FOR CESAREAN SECTION IN A PATIENT WITH SEVERE PERIPARTUM CARDIOMYOPATHY- A Case Report -

60

Anesthesia with Propofol in Grass Carp, Ctenopharyngodon idella, and its Effects on Electrocardiogram, Blood Gases and pH

61

Anesthesia, complications, and clinical outcome for ruptured intracranial aneurysms: a retrospective comparison between endovascular coiling and neurosurgical clipping

62

Anesthesia, Neural Information Processing, and Conscious Awareness

63

Anesthesia: Part of the solution

64

Anesthesia: The “Other Side” of Consciousness

65

Anesthesia—A Descent or a Jump into the Depths?

66

Anesthesia-Related Complaint Cases at Kermanshah Medical Council Between 1993 and 2011

67

Anesthesia-related morbidity and mortality: where are we? A descriptive study

68

Anesthésie générale en radiothérapie pédiatrique

69

Anesthesiologic and Surgical Experiences of the Spanish Role 2 Enhanced in Herat, Afghanistan

70

Anesthesiological approach to a case with FAHR syndrome

71

Anesthesiologist’s Perspective on a Child with Acute Lymphoblastic Leukemia undergoing Neurosurgery: Case Report

72

Anesthesiologists Have an Important Role in Preclinical Nurse Anesthesia Education

73

Anesthesiology residents’ perception towards educational environment using ATEEM in a medical school in Thailand

74

Anesthesiomics: Could a New Name Be Coined for Anesthesia?

75

Anesthetic action: The importance of the spinal cord to immobility

76

Anesthetic and analgesic efficacy, hemodynamic changes, andsedation following addition of dexmedetomidine to lignocainein intravenous regional anesthesia for minor hand surgery

77

ANESTHETIC AND ICU MANAGEMENT OF PERIPARTUM CARDIOMYOPATHY

78

Anesthetic approach to Niemann–Pick Type C patient for dental treatment

79

Anesthetic approach to patient with Down syndrome and Hallervorden-Spatz disease who underwent tooth extraction

80

Anesthetic Approach to the Patient with Intraabdominal Pseudocyst After Ventriculoperitoneal Shunt Dysfunction Performed for Hydrocephalus

81

Anesthetic Aspect Of Malaria Disease: A Brief Review

82

ANESTHETIC CARE OF THE PATIENT FOR ROBOTIC SURGERY

83

ANESTHETIC CARE OF THE PATIENT WITH OBSTRUCTIVE SLEEP APNEA

84

ANESTHETIC CHALLENGES IN ORO-FACIAL CLEFT REPAIR IN ILE-IFE, Nigeria

85

Anesthetic Challenges in Pregnancy with Wilson’s Disease Associated with Massive Splenomegaly Complicated with Intramyometrial Carboprost: A Case Report

86

ANESTHETIC CONSIDERATION FOR GERIATRIC OUTPATIENT

87

Anesthetic Consideration of Niemann-Pick Disease Type C

88

Anesthetic Considerations and Management of a Patient with Unsuspected Carcinoid Crisis During Hepa tic Tumor Resection

89

Anesthetic Considerations for Angelman Syndrome: Case Series and Review of the Literature

90

Anesthetic Considerations for Cataract Surgery in Patients with Parkinson’s Disease: A Narrative Review

91

ANESTHETIC CONSIDERATIONS FOR PEDIATRIC CHEST TRAUMA

92

ANESTHETIC CONSIDERATIONS FOR THE NEONATE WITH TRACHEOESOPHAGEAL FISTULA

93

Anesthetic Considerations for the Patient with Systemic Lupus Erythematosus

94

Anesthetic Considerations in a Case of Peumatocele Following Chest Trauma: A Case Report

95

Anesthetic Considerations in a Case With Massive Recurrent Clivus Chordoma

96

Anesthetic considerations in a patient with Psoriasis undergoing CABG surgery

97

Anesthetic considerations in a patient with Takayasu’s arteritisfor cesarean section

98

Anesthetic considerations in medium-chain acyl-CoA dehydrogenase deficiency

99

Anesthetic Considerations in Patients Undergoing Bariatric Surgery: A Review Article

100

ANESTHETIC CONSIDERATIONS IN PATIENTS WITH CARDIOMYOPATHIES- A Review -

101

Anesthetic considerations of Palmoplantar Keratoderma (PPK), a case report.

102

Anesthetic Considerations of Patient with Parry Romberg Syndrome

103

Anesthetic Considerations of Sporadic Inclusion Body Myositis in an Elderly Man With Orthopedic Trauma

104

Anesthetic Control of 40-Hz Brain Activity and Implicit Memory

105

Anesthetic Conversion of Preexisting Labor Epidural Analgesia for Emergency Cesarean Section and Efficacy of Levobupivacaine with or Without Magnesium Sulphate: A Prospective Randomized Study

106

ANESTHETIC DEATHS IN A DEVELOPING COUNTRY

107

Anesthetic dental needle breakage

108

Anesthetic effect of tricaine methanesulfonate, clove oil and electroanesthesia on lysozyme activity of Oncorhynchus mykiss

109

Anesthetic effects of adding intrathecal neostigmine or magnesium sulphate to bupivacaine in patients under lower extremities surgeries

110

Anesthetic Efficacy of Articaine and Ketamine for Inferior Alveolar Nerve Block in Symptomatic Irreversible Pulpitis: A Prospective Randomized Double-Blind Study

111

Anesthetic efficacy of articaine/epinephrine plus mannitol in comparison with articaine/epinephrine anesthesia for inferior alveolar nerve block in patients with symptomatic irreversible pulpitis: A randomized controlled clinical trial

112

Anesthetic Efficacy of Inferior Alveolar Nerve Block: Conventional versus Akinosi Technique

113

Anesthetic efficacy of ketamine, ketaminetramadol and ketamineketorolac in chicks

114

Anesthetic Efficacy of Lidocaine/Ketorolac in Inferior Alveolar Nerve Block in Patients with Irreversible Pulpitis: A Randomized Clinical Trial

115

Anesthetic Experience of 1000 Cases During 10 Years in Renal Transplantation: A Retrospective Study

116

Anesthetic gas control with neuro-fuzzy system in anesthesia

117

ANESTHETIC IMPLICATIONS OF ACUTE METHYLENEDIOXYMETHAMPHETAMINE INTOXICATION IN A PATIENT WITH TRAUMATIC INTRACEREBRAL HEMORRHAGE - Case Report-

118

Anesthetic Management “Arnold Chiari Malformation” in the well-known Case of Cystic Fibrosis

119

Anesthetic management and perioperative complications in transcatheter aortic valve implantation: the Turkish experience

120

Anesthetic Management and Postoperative Care of a Patient with CADASIL (Cerebral Arteriopathy, Autosomal Dominant, with Subcortical Infarcts and leukoencephalopathy) for Cesarean Section

121

Anesthetic management for elective lower segment cesareansection in a patient with systemic lupus erythematosus andthrombocytopenia

122

Anesthetic Management for Lower Limb Fracture in Severe Aortic Valve Stenosis and Fat Embolism: A Case Report and Review of Literature

123

Anesthetic Management for Tracheo-Bronchial Reconstruction

124

Anesthetic Management in a Child With Citrullinemia: A Case Report

125

Anesthetic Management in a Child With Niemann-Pick Disease

126

ANESTHETIC MANAGEMENT IN A PATIENT WITH CORNELIA DE LANGE SYNDROME

127

Anesthetic Management in a Patient with Mixed Connective Tissue Disease: a Case Report

128

Anesthetic Management in a Patient With Surgical Excision of Spinal Cords Hydatid Cyst: A Case Report

129

Anesthetic Management in a Patient With Type A Aortic Dissection and Superior Vena Cava Syndrome

130

Anesthetic Management in Complex Arch Surgery: Debranching of Innominate and Left Common Carotid Arteries in Extensive Aortic Dissection without Cardiopulmonary Bypass

131

Anesthetic Management of 29 Week Pregnant Patient Undergoing Craniotomy for Pituitary Macroadenoma

132

Anesthetic Management of a Case of Duchenne Muscular Dystrophy in Congestive Heart Failure with Compartment Syndrome of the Upper Limb for Emergency Fasciotomy

133

Anesthetic management of a dog with severe subaortic stenosis and mitral valve disease complicated with atrial fibrillation undergoing ovariohysterectomy

134

Anesthetic management of a low birth weight infant with immature teratoma

135

ANESTHETIC MANAGEMENT OF A MORBIDLY OBESE PARTURIENT UNDERGOING CESAREAN SECTION

136

ANESTHETIC MANAGEMENT OF A NEWBORN WITH A CERVICAL MENINGOMYELOCELE

137

Anesthetic Management of a Parturient with Spinal Muscle Atrophy for Cesarean Section: A Case Report

138

Anesthetic Management of a Patient with Achondroplasia Undergoing Adenotonsillectomy: A Case Report

139

Anesthetic Management of a Patient with DRESS Syndrome for Renal Transplantation

140

ANESTHETIC MANAGEMENT OF A PATIENT WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY UNDERGOING MODIFIED RADICAL MASTECTOMY

141

Anesthetic Management of a Patient with Myasthenia Gravis

142

ANESTHETIC MANAGEMENT OF A PATIENT WITH MYOTONIC DYSTROPHY FOR LAPAROSCOPIC CHOLECYSTECTOMY - A Case Report -

143

Anesthetic management of a patient with Nager Syndrome

144

Anesthetic management of a patient with β -thalassemia and superimposed pneumonia

145

Anesthetic Management of a Pediatric Patient with Arginase Deficiency

146

Anesthetic management of a scleroderma patient undergoing tricuspid valve replacement under cardiopulmonary bypass

147

ANESTHETIC MANAGEMENT OF ACHONDROPLASTIC DWARF UNDERGOING CESAREAN SECTION

148

Anesthetic Management of Achondroplastic Dwarf with Difficult Airway for Cadaveric Renal Transplantation: A Case Report

149

Anesthetic Management of an Infant Presenting with an Intrapericardial Tumor: A Case Report

150

Anesthetic Management of an Infant with Bilateral Radial Dysplasia and Isolated Patent Ductus Arteriosus: A Case Report and Brief Review of Literature

151

Anesthetic management of carcinoma of thyroid involving trachea in a patient with hypertrophic obstructive cardiomyopathy

152

Anesthetic Management of Cervical Disc Herniation in a Patient with Churg-Strauss Syndrome: A Case Report

153

Anesthetic Management of Cervical Disc Herniation in a Patient with Churg-Strauss Syndrome: A Case Report

154

Anesthetic management of children with Moyamoya disease

155

ANESTHETIC MANAGEMENT OF CHILDREN WITH RUBINSTEIN-TAYBI SYNDROME

156

Anesthetic management of conjoined twins undergoing one-stage surgical separation: A single center experience

157

Anesthetic Management of COVID-19 Associated Mucormycosis: A Narrative Review

158

ANESTHETIC MANAGEMENT OF CRITICALLY ILL PREGNANT WOMEN

159

Anesthetic management of diaphragmatic hernia repair in a dog: a case report and literature review of anesthetic techniques

160

Anesthetic Management of Difficult Airway Due to Maxillofacial Trauma in a Pregnant Patient Requiring Submental Intubation: A Case Report

161

ANESTHETIC MANAGEMENT OF DILATED CARDIOMYOPATHY - A Case report -

162

Anesthetic Management of Hysterosalpingo-oophorectomy in a Case with Severe Idiopathic Dilated Cardiomyopathy

163

ANESTHETIC MANAGEMENT OF IATROGENIC ESOPHAGEAL PERFORATION - Case Report and Literature Review -

164

Anesthetic management of ischemic heart disease with ejectionfraction of 35% in a patient of fracture neck femur

165

Anesthetic Management of Jervell and Lange-Nielsen Syndrome With Long QT Undergoing Surgical Sympathectomy: A Pediatric Case Report

166

Anesthetic management of laparoscopic dual renal transplantation

167

Anesthetic Management of Patients With Anterior Mediastinal Masses Undergoing Chamberlain Procedure (Anterior Mediastinostomy)

168

Anesthetic management of patients with Klippel-Feil syndrome, a case series

169

ANESTHETIC MANAGEMENT OF PEDIATRIC CARDIAC PATIENTS UNDERGOING NON CARDIAC SURGERY

170

ANESTHETIC MANAGEMENT OF PHEOCHROMOCYTOMA

171

Anesthetic Management of Rapid Ventricular Response Atrial Fibrillation in an Elderly Woman Using Remifentanil; A Case Report

172

Anesthetic Management of Simultaneous Coronary Artery bypass Grafting with Cardiopulmonary bypass and Extended Thymectomy in a Patient with Myasthenia Gravis

173

Anesthetic Management of T12 Schwannoma in a Patient with Churg-Strauss Syndrome: A Case Report

174

Anesthetic Management of Total Traumatic Avulsion of Mandible

175

Anesthetic Management ofUrgent Cesarean Section withUndiagnosed Transposition ofGreat Arteries

176

Anesthetic Management Recommendations Using a Machine Learning Algorithm to Reduce the Risk of Acute Kidney Injury After Cardiac Surgeries

177

Anesthetic Management with Epidural Analgesia in a Case of Thalassemia Intermedia

178

Anesthetic methods for reduction of acute shoulder dislocations: A prospective randomized study comparing intraarticular lidocaine with intravenous analgesia and sedation

179

Anesthetic pentobarbital inhibits proliferation and migration of malignant glioma cells

180

Anesthetic Propofol-Induced Gene Expression Changes in Patients Undergoing Coronary Artery Bypass Graft Surgery Based on Dynamical Differential Coexpression Network Analysis

181

Anesthetic Technique in a Patient With Multiple Sclerosis Scheduled for Laparoscopic Nephrectomy for a Renal Tumor: A Case Report

182

Anesthetic Technique Influences Brain Temperature During Cardiopulmonary Bypass in Dogs

183

Anesthetic techniques for pediatric thoracoscopy

184

ANESTHETIST EXPERIENCE FOR CLEFT LIP AND CLEFT PALATE REPAIR: A REVIEW OF 172 SMILE TRAIN SPONSORED PATIENTS AT HAYAT ABAD MEDICAL COMPLEX, PESHAWAR

185

AnestimationmethodforbasematupliftbehaviorofnuclearpowerplantbuildingsOriginalResearchArticle

186

Anethole, a Medicinal Plant Compound, Decreases the Production of Pro-Inflammatory TNF-α and IL-1β in a Rat Model of LPS-Induced Periodontitis

187

Anethum graveolens and hyperlipidemia: A randomized clinical trial

188

Anethum graveolens L‎. Alleviates Sperm ‎Damage by Limiting Oxidative Stress ‎and Insulin ‎Resistance ‎in ‎Diabetic Rats

189

Anethum Graveolens Linn (Umbelliferae) Extract Attenuates Stress-induced Urinary Biochemical Changes and Improves Cognition in Scopolamineinduced Amnesic Rats

190

Anethum graveolens seeds aqueous extract stimulates whole brain 5-hydroxytryptamine metabolism and reduces feeding behavior and body weight in obese rats

191

Anethum graveolens Supplementation Improves Insulin Sensitivity and Lipid Abnormality in Type 2 Diabetic Patients

192

Anethum graveolens, A new host of Meloidogyne incognita in Turkey

193

Aneugenic 2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one (DIMBOA) and 2,4-dihydroxy-1,4-benzoxazin-3-one (DIBOA) in sprouts of Triticum aestivum cultivars – A ‘safety health food’?

194

AN-EUL method for automatic interpretation of potential field data in unexploded ordnances (UXO) detection

195

Aneuploidies, deletion, and overexpression of TP53 gene in intestinal metaplasia of patients without gastric cancer

196

Aneuploidy Acts Both Oncogenically and as a Tumor Suppressor

197

Aneuploidy and Consistent Structural Chromosome Changes Associated with Transformation of Syrian Hamster Embryo Cells

198

Aneuploidy as a counter to “Mullerʹs ratchet” in cancer cells

199

Aneuploidy frequencies in semen fractions from ten oligoasthenoteratozoospermic patients donating sperm for intracytoplasmic sperm injection

200

Aneuploidy of chromosome 20 in invasive breast cancer correlates with poor outcome

201

Aneuploidy Precedes and Segregates with Chemical Carcinogenesis

202

Aneuploidy theory explains tumor formation, the absence of immune surveillance, and the failure of chemotherapy

203

Aneuploidy Underlies Rapid Adaptive Evolution of Yeast Cells Deprived of a Conserved Cytokinesis Motor

204

Aneuploidy, chromosomal missegregation, and cell cycle reentry in Alzheimer’s disease

205

Aneurismal disease of different vascular territories: Is it a rare association?

206

Aneurysm after subclavian flap angioplasty repair of coarctation of the aorta

207

Aneurysm at the fenestrated anterior cerebral artery: Surgical anatomy and management

208

Aneurysm formation after patch aortoplasty repair (vossschulte): reoperation in adults with and without hypothermic circulatory arrest

209

Aneurysm of a Right-Sided Descending Aorta With a Normal Left-Sided Aortic Arch

210

Aneurysm of ascending and descending aorta in a 10-year-old-boy with Wiskott-Aldrich syndrome

211

Aneurysm of Brachial Artery Following Axillary Crutch

212

Aneurysm of circumflex coronary artery caused by cardiac vein and fistulous connection to the left ventricle identified on MDCT

213

Aneurysm of fossa ovalis in adults: A pathologic study

214

Aneurysm of saphenous vein bypass graft detected by first-pass radionuclide ventriculography, , ,

215

Aneurysm of saphenous vein graft causing anterior myocardial infarction by possibly compressing left internal mammary artery

216

Aneurysm of Sinus of Valsalva Dissecting Into Interventricular Septum

217

Aneurysm of sinus of Valsalva with extensive dissection of interventricular septum and left ventricular free wall

218

Aneurysm of the aortic root in the setting of Wiskott-Aldrich syndrome

219

Aneurysm of the iliac artery in an infant: Diagnosis by angiography with computed tomography (In French) : Arnould V, Worms A-M, Galloy M-A, Hoeffel J-C (J.C.H.: Service de Radiologie, Hôpital dʹEnfants de Vandoeuvre les Nancy, allée du Morvan, F-54511, V

220

Aneurysm of the Internal Carotid Artery Misdiagnosed as Cervical Paraganglioma; A Case Report and Literature Review

221

Aneurysm of the left atrial appendage

222

Aneurysm of the left pulmonary artery: surgical allograft repair

223

Aneurysm of the Left Sinus of Valsalva Producing Aortic Valve Regurgitation and Myocardial Ischemia

224

Aneurysm of the membranous interventricular septum demonstrated by multislice computed tomography

225

Aneurysm of the membranous ventricular septum resulting in pulmonary outflow tract obstruction in congenitally corrected transposition of the great arteries, ,

226

Aneurysm of the Mitral Valve: A Rare Complication of Aortic Valve Endocarditis

227

Aneurysm of the Pulmonary Artery in Fallot’s Tetralogy

228

Aneurysm of the right renal vein arising from an idiopathic arteriovenous fistula

229

Aneurysm shrinkage after endovascular repair of aortic diseases

230

Aneurysm Surgery: Step by Step to Meet the God

231

Aneurysmal Aorto-Left Ventricular Tunnel

232

Aneurysmal Bone Cyst after Femoral Derotational Osteotomy: A Case Report

233

Aneurysmal Bone Cyst in the First Rib

234

Aneurysmal Bone Cyst of Sphenoid Bone-A Case Report

235

Aneurysmal Bone Cyst of the Capitate: A rare case report

236

Aneurysmal bone cyst of the orbit: A case of rare location and review of the literature

237

Aneurysmal bone cyst originating from the first rib

238

Aneurysmal bone cyst with chromosomal changes involving 7q and 16p

239

Aneurysmal Bone Cyst: An Analysis of 38 Cases and Report of Four Unusual Surface Ones

240

Aneurysmal Bone Cyst: An Analysis of 38 Cases and Report of Four Unusual Surface Ones

241

Aneurysmal bone cyst-like areas as a sign of metastatic disease in the spinal column

242

Aneurysmal change in an internal mammary artery–pulmonary artery fistula

243

Aneurysmal Dilatation of the Contegra Bovine Jugular Vein Conduit After Reconstruction of the Right Ventricular Outflow Tract

244

Aneurysmal femoral neck cyst: Report of a paediatric case and review of literature

245

Aneurysmal pericardial patch producing right ventricular inflow obstruction

246

Aneurysmal rebleeding episode after lumbar puncture

247

Aneurysmal wall calcification predicts natural history of small abdominal aortic aneurysms

248

Aneurysmal walls in unruptured intracranial aneurysms

249

Aneurysmosis presenting as acute limb ischemia

250

Aneurysms After Coarctation Repair Associated With Hypoplastic Aortic Arch: Surgical Management Through Median Sternotomy

251

Aneurysms and Aortic Insufficiency: Two Very Rare Complications of Wilson’s Disease

252

Aneurysms complicating pulmonary autograft procedure for aortic valve replacement

253

Aneurysms of Sinus of Valsalva

254

Aneurysms of the portal venous system: Gray-scale and color doppler ultrasonographic findings with CT and mri correlation

255

Aneurysms of the Sinus of Valsalva in a Patient with Behcet's Disease

256

Aneurysms unsuitable for endovascular intervention: Surgical outcome and management challenges over a 5-year period following International Subarachnoid Haemorrhage Trial (ISAT)

257

Aneusomy detection by fluorescence in situ hybridization (FISH) using bladder washings: correlation with cytology, cytogenetics and clinical features predicts recurrence and defines test limitations

258

Aneusomy for detection of bladder cancer recurrence: a Southwest Oncology Group study

259

Aneutronics–thermalhydraulicsmodelforpreliminarystudiesonTRADEdynamicsOriginalResearchArticle

260

AnevaluationofreactorcoolingandcoupledhydrogenproductionprocessesusingthemodularheliumreactorOriginalResearchArticle

261

Anevaluationofriskmethodsforprioritizingfireprotectionfeatures:aprocedureforfirebarrierpenetrationsealsOriginalResearchArticle

262

ANew Algorithm to Impute the MissingValues in the Multivariate Case

263

ANew Low-Temperature Preparations of Some Simple and Mixed Co and Ni Dispersed Sulfides and Their Chemical Behavior in Reducing Atmosphere

264

ANew Scheme for Storage and Retrieval of Shared Text Files

265

Anewapproachtodesigningreducedscalethermal-hydraulicexperimentsOriginalResearchArticle

266

A-New-Closed-form-Mathematical-Approach-to-Achieve Minimum Phase Noise in Frequency Synthesizers

267

AnewfinitecloudmethodforcalculatingexternalexposuredoseinanuclearemergencyOriginalResearchArticle

268

AnewLMRsteamgeneratorfreefromSWRwithadoubletubebundleconfigurationOriginalResearchArticle

269

Anewphenomenologicalcriterionforpellet–claddinginteractionruptureOriginalResearchArticle

270

AnewversionofthereflectedcoreinhourequationanditssolutionOriginalResearchArticle

271

AnexperimentalandanalyticalstudyoftheeffectofaxialpowerprofileonCHFOriginalResearchArticle

272

AnexperimentalinvestigationonthecriticalheatfluxenhancementbymechanicalvibrationinverticalroundtubeOriginalResearchArticle

273

AnexperimentalstudyonquenchingofaradiallystratifiedheatedporousbedOriginalResearchArticle

274

Anexperimentalstudyonthecriticalheatfluxforlowflowofwaterinanon-uniformlyheatedverticalrodbundleoverawiderangeofpressureconditionsOriginalResearchArticle

275

AnexperimentalvalidationoftheguidelineforinelasticdesignanalysisthroughstructuralmodeltestsOriginalResearchArticle

276

AnF1-Module for the 3U4(3)-Amalgam Original Research Article

277

AnF1-Module for the 3U4(3)-Amalgam Original Research Article

278

Anfälle. Erfahrungen mit Epilepsie. Edited by Stefan Heiner, Margret Meyer-Brauns, and Lotte Habermann-Horstmeier

279

ANFIS and statistical based approach to prediction the peak pressure load of concrete pipes including glass fiber

280

ANFIS based Distillation Column Control

281

ANFIS Based Modeling of the Hormonal Effects of GLP-2 on the Mean Arterial Pressure and Blood Volume of Rats

282

ANFIS Controller for Non-holonomic Robots

283

ANFIS Controller for Non-holonomic Robots

284

ANFIS for high-pressure waterjet cleaning prediction

285

ANFIS modeling and validation of a variable speed wind turbine based on actual data

286

ANFIS Modeling to Forecast Maintenance Cost of Associative Information Technology Services

287

ANFIS Modelling of Carbon and Nitrogen Removal in Domestic Wastewater Treatment Plant

288

ANFIS modelling of the performance and emissions of a diesel engine using diesel fuel and biodiesel blends

289

ANFIS Speed Controller of IM Drives with Three-level DTC-based Neural Network

290

ANFIS-Based Diagnosis and Location of Stator Interturn Faults in PM Brushless DC Motors

291

ANFIS-based estimation of PV module equivalent parameters: application to astand-alone PV system with MPPT controller

292

ANG II activates P38 MAP kinase and ERK1/2, but not JNK, in vascular smooth muscle cells from SHR

293

Ang II-stimulated generation of reactive oxygen species in human vascular smooth muscle cells is mediated via PLD-dependent pathways

294

Angel investors and the market for angel investments

295

Angel Rain (Tishtar): Case Study of Boghe of Gilan and Saghanefars of Mazandaran

296

Angel, handmaiden, battleaxe or whore? A study which examines changes in newly recruited student nurses’ attitudes to gender and nursing stereotypes

297

Angela Carter’s Heroes and Villains: A Dystopian Romance

298

Angelic machines: A philosophical dialogue (2)

299

Angelic semantics of fine-grained concurrency

300

Angelica archengelica extract induced perturbation of rat skin and tight junctional protein (ZO-1) of HaCaT cells

301

Angelica stimulates proliferation of murine bone marrow mononuclear cells by the MAPK pathway

302

Angelicae Gigantis Radix regulates mast cell-mediated allergic inflammation in vivo and in vitro

303

Angelman Syndrome: A Case Report

304

Angelman syndrome: a review of clinical and genetic aspects

305

Angelman Syndrome: Finding the Lost Arc

306

Angelman syndrome: is there a characteristic EEG?

307

Angelmarin, a novel anti-cancer agent able to eliminate the tolerance of cancer cells to nutrient starvation

308

Angelo Peccerillo, Plio-Quaternary volcanism in Italy: Petrology, geochemistry, geodynamics,

309

Angelonia flower mottle, a new disease of Angelonia angustifolia caused by a hitherto unknown carmovirus

310

Angels and spirits in the world of illness

311

Angels in the details: Comment on “The relationship between destination proximity, destination mix and physical activity behaviors”

312

Anger and aggression among drivers in three European countries

313

Anger- and aggression-related traits are associated with polymorphisms in the 5-HT-2A gene

314

Anger and anger expression in relation to perceptions of social rank, entrapment and depressive symptoms

315

Anger and blood pressure readings in children

316

Anger and Gender Effects in Observed Supervisor-Subordinate Dyadic Interactions

317

Anger and hostility in adolescents: Relationships with self-reported attachment style and perceived parental rearing styles

318

Anger and hostility in maritally violent men: Conceptual distinctions, measurement issues, and literature review

319

Anger and hostility linked to coronary heart disease

320

Anger and impulsivity in non-clinical women

321

Anger and inhibitory control as moderators of childrenʹs hostile attributions and aggression

322

Anger and inhibitory control as moderators of childrenʹs hostile attributions and aggression

323

Anger and Irritability Symptoms among Youth with ODD: Cross-Informant Versus Source-Exclusive Syndromes

324

Anger and personality in eating disorders

325

Anger and psychopathology in prison inmates

326

Anger and somatization

327

Anger and the behavioral approach system

328

Anger as a cue to truthfulness

329

Anger as a Psychological Risk Factor of Hypertension

330

Anger assessment with the STAXI-CA: psychometric properties of a new instrument for children and adolescents

331

Anger at graphic evidence at Omagh inquest

332

Anger at US transplant waiting times “scare”

333

Anger Attacks in Major Depressive Disorder and Serum Levels of Homocysteine

334

Anger expression and essential hypertension: Behavioral response to confrontation

335

Anger expression in children and adolescents: A review of the empirical literature

336

Anger expression in Swiss adolescents: Establishing measurement invariance across gender in the AX scales

337

Anger expression, coping, and substance use in adolescent offenders

338

Anger expression, partner support, and quality of life in cancer patients

339

Anger in Adolescent Boy Athletes: a Comparison among Judo, Karate, Swimming and Non Athletes

340

Anger in chronic pain: Investigations of anger targets and intensity

341

Anger in healthy men: a PET study using script-driven imagery

342

Anger in prisoners: women are different from men

343

Anger in the Trajectory of Healing From Childhood Maltreatment

344

Anger in UK as discredited doctor is elected to doctorsʹ ruling body

345

Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids

346

Anger Management among Medical Undergraduate Students and Its Impact on Their Mental Health and Curricular Activities

347

Anger Management and Control in Social and Behavioral Sciences: A Systematic Review of Literature on Biopyschosocial Model

348

Anger Management and Factors that Influence Anger in Physicians

349

Anger Management May Save Your Life: New Insights Into Emotional Precipitants of Ventricular Arrhythmias

350

Anger management style and the prediction of treatment outcome among male and female chronic pain patients

351

Anger on ruling not to prosecute Irish doctors

352

Anger over dangerous withdrawal of antipsychotics from Pakistan

353

Anger over handling of Madagascarʹs cholera epidemic

354

Anger response styles and reaction to provocation

355

Anger rumination in Hong Kong and Great Britain: Validation of the scale and a cross-cultural comparison

356

Anger scale and anger types of patients with fifth metacarpal neck fracture

357

Anger scale and anger types of patients with fifth metacarpal neck fracture

358

Anger superiority effect for change detection and change blindness

359

Anger suppression mediates the relationship between optimism and natural killer cell cytotoxicity in men treated for localized prostate cancer

360

Anger symptoms and “delinquent” behavior in Tourette syndrome with and without attention deficit hyperactivity disorder

361

Anger types and the use of cigarettes and smokeless tobacco among Native American adolescents

362

Anger, aggression, and risky behavior: a comparison of high and low anger drivers

363

Anger, aggression, risky behavior, and crash-related outcomes in three groups of drivers

364

Anger, Anger Expression, and Suicidal Ideation in Korean Adolescents

365

Anger, Depression, and Anxiety in Cardiac Patients: The Complexity of Individual Differences in Psychological Risk

366

Anger, depression, and coping interactions in headache activity and adjustment: a controlled study

367

Anger, hostility, and male perpetrators of intimate partner violence: A meta-analytic review

368

Anger, negative emotions, and cardiovascular reactivity during interpersonal conflict in women

369

Anger, over-control and serious violent offending

370

Anger, psychopathology and cognitive inhibition: a study of UK servicemen

371

Anger, Suppressed Anger, and Risk of Adverse Events in Patients With Coronary Artery Disease

372

Anger-associated panic attacks in Cambodian refugees with PTSD; a multiple baseline examination of clinical data

373

Anger-in and hostility in myocardial infarction patients

374

Anger-Induced T-Wave Alternans Predicts Future Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators

375

Angerlike behavioral state potentiates myocardial ischemia-induced T-wave alternans in canines

376

Anggaran dan Ciri Fizikokimia Sisa Buangan Makanan di Bandar Baru Bangi

377

angian lattice boltzmann method for euler equati

378

Angina 1 year after percutaneous coronary intervention: A report from the NHLBI Dynamic Registry

379

Angina and origin of three major coronary arteries from independent ostia in right coronary sinus

380

Angina and sudden cardiac death caused by anomalous right coronary artery origin from above the left coronary cusp

381

Angina bullosa hemorrhagica: an idiopathic intraoral blistering disorder

382

Angina caused by coronary steal phenomenon

383

Angina caused by systolic compression of the left coronary artery as a result of pseudoaneurysm of the mitral-aortic intervalvular fibrosa

384

Angina for 14 years

385

Angina Pectoris and Atherosclerotic Risk Factors in the Multisite Cardiac Lifestyle Intervention Program

386

Angina pectoris and myocardial infarction with the use of leuprolife acetate

387

Angina pectoris caused by coronary microvascular spasm

388

Angina pectoris caused by microvascular spasm

389

Angina pectoris caused by microvascular spasm

390

Angina Pectoris or Myocardial Infarctions, Pulmonary Arteriovenous Malformations, Hereditary Hemorrhagic Telangiectasia, and Paradoxical Emboli

391

Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling Original Research Article

392

Angina pectoris: a headache

393

Angina reassessed: pain or protector?

394

Angina Self-Management Plan and Quality of Life, Anxiety and Depression in Post Coronary Angioplasty Patients

395

Angina symptoms in men and women with stable coronary artery disease and evidence of exercise-induced myocardial perfusion defects

396

Angina-Induced Protection Against Myocardial Infarction in Adult and Elderly Patients: Loss of Preconditioning Mechanism in the Aging Heart?

397

Anginal Status and Prediction of Cardiac Events in Patients Enrolled in the Asymptomatic Cardiac Ischemia Pilot (ACIP) Study

398

Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease

399

Angioarchitecture and blood circulation in focal nodular hyperplasia of the liver

400

Angioarchitecture of monochorionic placentas in relation to the twin-twin transfusion syndrome

401

Angioarrestin mRNA expression in early-stage lung cancers

402

Angio-Associated Migratory Cell Protein and Smooth Muscle Cell Migration in Development of Restenosis and Atherosclerosis

403

Angioblasts in peripheral blood

404

Angiocardiographic findings in patients with biphasic T-wave inversion in precordial leads

405

Angiocardiography and magnetic resonance imaging to assess pulmonary regurgitation in repaired tetralogy of Fallot

406

Angiocentric Nasal T-Cell Lymphoma in a Patient with Idiopathic CD4+ Lymphocytopenia

407

Angiodysplasia: New Look at an Old Conundrum

408

Angiodysplastic lesions as a cause of colonic bleeding in patients with chronic renal disease: is there an association?

409

Angioedema and urticaria as early presentations of a COVID-19 patient: a case report

410

Angioedema Associated With Droperidol Administration, , ,

411

Angioedema Associated with Haloperidol

412

Angioedema associated with sumatriptan administration

413

Angioedema due to acquired C1-inhibitor deficiency: A bridging condition between autoimmunity and lymphoproliferation

414

Angioedema Due to Lamiaceae Allergy

415

Angioedema Due to Lamiaceae Allergy

416

Angioedema in a Patient with C1 Esterase Inhibitor Deficiency

417

Angioedema related to the ue of hyaluronidae in cataract urgery

418

Angioedema. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society (PTD) and Polish Society of Allergology (PTA)

419

Angioembolization as an effective alternative for hemostasis in intractable life-threatening maxillofacial trauma hemorrhage: case study

420

Angioembolization in itractable epistaxis — a tertiary care experience

421

Angioemboliziation of Internal Pudendal Artery for Treatment of Long Lasting Gross Hematuria After Transurethral Resection of the Prostate

422

Angiofibroma of the Nasal Septum

423

Angiofollicular lymph node hyperplasia (Castlemanʹs disease)

424

Angiogenèse et radiothérapie : tout ce qu’un oncologue radiothérapeute doit savoir

425

Angiogenesis and anti-angiogenesis in hepatocellular carcinoma

426

Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma

427

Angiogenesis and breast cancer

428

Angiogenesis and breast cancer metastasis

429

Angiogenesis and chronic disease

430

Angiogenesis and functional recovery demonstrated after minor stroke

431

Angiogenesis and growth factor expression in a model of transmyocardial revascularization

432

Angiogenesis and growth factor modulation induced by alternagin C, a snake venom disintegrin-like, cysteine-rich protein on a rat skin wound model

433

Angiogenesis and hepatocellular carcinoma

434

Angiogenesis and intrauterine growth restriction

435

Angiogenesis and Its Targeting in Glioblastoma with Focus on Clinical Approaches

436

Angiogenesis and Mast Cells Density in Oral and Esophageal Squamous Cell Carcinomas

437

Angiogenesis and Minimal Residual Disease in Patients with Acute Myeloid Leukemia

438

Angiogenesis and molecular biologic substaging in patients with stage I non—small cell lung cancer

439

Angiogenesis and Morphometry of Bovine Placentas in Late Gestation from Embryos Produced In Vivo or In Vitro

440

Angiogenesis and musculogenesis as two facets of inflammatory post-ischemic tissue regeneration

441

Angiogenesis and Nitric Oxide in Elderly Men after Continuous and Interval Aerobic Training

442

Angiogenesis and placental growth in normal and compromised pregnancies

443

Angiogenesis and Tumor-Associated Macrophages in Different Grades of Oral Squamous Cell Carcinoma, Verrucous Carcinoma and Epithelial Dysplasia via Immunohistochemical Assessment of Expression of CD34 and CD68 Markers

444

Angiogenesis and vascular endothelial growth factor expression in the equine corpus luteum

445

Angiogenesis as targeted breast cancer therapy

446

Angiogenesis assays

447

ANGIOGENESIS EFFECTS OF CHINESE HERBAL SALVIA MILTIORRHIZA AFTER ACUTE MYOCARDIAL INFARCTION IN RATS

448

Angiogenesis factor in endometrial carcinoma: A new prognostic indicator?, ,

449

Angiogenesis Following Three-Dimensional Culture of Isolated Human Endometrial Stromal Cells

450

Angiogenesis Following Three-Dimensional Culture of Isolated Human Endometrial Stromal Cells

451

Angiogenesis in bone fracture healing: A bioregulatory model

452

Angiogenesis in cervical intraepithelial neoplasia and the risk of recurrence, ,

453

Angiogenesis in chronic myelogenous leukaemia

454

Angiogenesis in chronic myelogenous leukaemia

455

Angiogenesis in colon hyperplastic polyp

456

Angiogenesis in ductal breast carcinoma and its correlation with the prognostic parameters

457

Angiogenesis in ductal breast carcinoma. Comparison of microvessel density between primary tumour and lymph node metastasis

458

Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation

459

Angiogenesis in ischemic human myocardium: clinical results after 3 years

460

Angiogenesis in Ischemic Stroke Patients Aged 30 - 80 years at Gatot Subroto Army Central Hospital (RSPAD) Jakarta

461

Angiogenesis in neovascularized free muscle grafts

462

Angiogenesis in odontogenic keratocyst and dentigerous cyst: Evaluation of JunB and VEGF expression

463

ANGIOGENESIS IN OPEN TIBIAL FRACTURES: A COMPARISON OF MUSCLE AND FASCIOCUTANEOUS FLAPS

464

Angiogenesis in ovarian cancer

465

Angiogenesis in ovarian follicular and luteal development

466

Angiogenesis in primary and metastatic epithelial ovarian carcinoma, ,

467

Angiogenesis in Rat Ischemic Hindlimb: Role of Human Bone Marrow-Derived Mesenchymal Stem Cells Transplantation

468

Angiogenesis in the Pathobiology and Treatment of Vascular and Malignant Diseases

469

ANGIOGENESIS IN TISSUE ENGINEERING

470

Angiogenesis in transmyocardial revascularization: comparison of laser versus mechanical punctures

471

Angiogenesis induced by autologous whole bone marrow stem cells seeded on collagen scaffolds in silicone nerve tubes. An experimental study

472

Angiogenesis induced by urothelial cells (HCV-29) and their v-ras and v-raf transfectants

473

Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: History and rationale

474

Angiogenesis inhibitor DC101 delays growth of intracerebral glioblastoma but induces morbidity when combined with irradiation

475

Angiogenesis inhibitor TX-1898: syntheses of the enantiomers of sterically diverse haloacetylcarbamoyl-2-nitroimidazole hypoxic cell radiosensitizers Original Research Article

476

Angiogenesis inhibitors derived from thalidomide

477

Angiogenesis Is Enhanced in Ischemic Canine Myocardium by Transmyocardial Laser Revascularization

478

Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction

479

Angiogenesis modulatory activity of SC-CO2 leaf extract of guyabano (Annona muricata Linn.) using chick embryo chorioallantoic membrane assay

480

Angiogenesis of the ovary,

481

Angiogenesis Status in Patients with Acute Myeloid Leukemia: From Diagnosis to Post-hematopoietic Stem Cell Transplantation

482

Angiogenesis with recombinant fibroblast growth factor-2 for claudication

483

Angiogenesis with recombinant fibroblast growth factor-2 for claudication

484

ANGIOGENESIS WITHIN ATHEROSCLEROTIC LESIONS BY STEM/PROGENITOR CELLS

485

Angiogenesis, Arteriogenesis, and Diabetes: Paradigm Reassessed?

486

Angiogenesis, myogenesis and cell therapy I

487

Angiogenesis, Myogenesis, and Cell Therapies

488

Angiogenesis, tumor necrosis factor-α and procoagulant factors in coronary artery giant aneurysm of a fatal infantile Kawasaki disease

489

Angiogenesis/myogenesis cell therapy

490

Angiogenesis/myogenesis/cell therapy II

491

Angiogenesis: A Critical Role in Locally Aggressive Behavior of Keratocystic Odontogenic Tumor

492

Angiogenic activitiy of syndecan-binding laminin peptide AG73 (RKRLQVQLSIRT)

493

Angiogenic activity in the sera of patients with post-kidney transplant erythrocytosis

494

Angiogenic and inflammatory response to biodegradable scaffolds in dorsal skinfold chambers of mice

495

Angiogenic Effect of Leptin in the Quail Chorioallantoic Membrane

496

Angiogenic effect of naive and 5-fluorouracil resistant colon carcinoma on endothelial cells in vitro

497

Angiogenic effect of prostaglandin I 2 in relation with its effect on PPAR nuclear receptors

498

Angiogenic effect of the aqueous extract of Cynodon dactylon on human umbilical vein endothelial cells and granulation tissue in rat

499

ANGIOGENIC EFFECTS OF A NEW HMG-COA REDUCTASE INHIBITOR, PITAVASTATIN

500

Angiogenic Effects of Aerobic Training and Royal Jelly Consumption with Emphasis on the Role of miR-126 and miR-210 in the Aortic Artery of Ovariectomized Diabetic Rats

501

Angiogenic factors and the risk of preeclampsia: A systematic review and meta-analysis

502

Angiogenic factors in chronic liver diseases: the effects on hepatic progenitor cells

503

Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease

504

Angiogenic growth factors in human dentine matrix

505

Angiogenic growth factors released in human dental pulp following orthodontic force

506

Angiogenic induction and cell migration in an orthopaedically expanded maxillary suture in the rat

507

Angiogenic output in viral hepatitis, C and B, and HCV-associated hepatocellular carcinoma

508

Angiogenic response induced by acellular femoral matrix in vivo

509

Angiogenic responses are enhanced in mechanically and microscopically characterized, microbial transglutaminase crosslinked collagen matrices with increased stiffness

510

Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction

511

Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate: An experimental study

512

Angiogenin and osteopontin and coronary collateral circulation

513

Angiogenin plasma levels during pregnancy

514

Angiogenin: A marker for preterm delivery in midtrimester amniotic fluid, , , ,

515

Angiograph image restoration with the use of rule base fuzzy 2D Kalman filter

516

Angiographic 5-year follow-up study of right gastroepiploic artery grafts

517

Angiographic Adverse Events, Creatine Kinase-MB Elevation, and Ischemic End Points Complicating Percutaneous Coronary Intervention (a REPLACE-2 Substudy)

518

Angiographic Analysis of Pattern of Late Luminal Loss in Sirolimus- and Paclitaxel-Eluting Stents

519

Angiographic Analysis of the Anatomic Relation of Coronary Arteries to Mitral and Tricuspid Annulus and Implications for Radiofrequency Ablation

520

Angiographic analysis of the angioplasty versus rotational atherectomy for the treatment of diffuse in-stent restenosis trial (ARTIST)

521

Angiographic anatomical variation of origin of left circumflex coronary artery in Basrah

522

Angiographic anatomy of the grafted left internal mammary artery

523

Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction tria

524

Angiographic and clinical characteristics associated with the development of q-wave and non-q–wave myocardial infarction in the thrombolysis in myocardial infarction (timi) 14 trial

525

Angiographic and clinical outcome following coronary stenting of small vessels : comparison with coronary stenting of large vessels

526

Angiographic and clinical outcome of mild to moderate nonocclusive unstented coronary artery dissection and the influence on coronary flow velocity reserve

527

Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction

528

Angiographic and clinical outcomes following acute infarct angioplasty on saphenous vein grafts

529

Angiographic and clinical outcomes of late total occlusion versus treatment failure without late total occlusion in patients after intracoronary radiation therapy for in-stent restenosis

530

Angiographic and clinical outcomes of polytetrafluoroethylene-covered stent use in significant coronary perforations

531

Angiographic and Interventional Radiological Management of Obscure Overt Gastrointestinal Bleeding

532

Angiographic and intravascular ultrasound predictors of in-stent restenosis

533

Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: Comparison with same drug-eluting overlapping stents

534

Angiographic and Magnetic Resonance Imaging Evaluation of In-Hospital Delay in Primary Percutaneous Intervention Delivery on Myocardial Salvage

535

Angiographic and morphologic features of the left ventricle in Ebsteinʹs malformation

536

Angiographic and procedural outcome after coronary angioplasty in high-risk subsets using a decremental diameter (tapered) balloon catheter

537

Angiographic and prognostic implications of an exaggerated exercise systolic blood pressure response and rest systolic blood pressure in adults undergoing evaluation for suspected coronary artery disease

538

Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries

539

Angiographic and volumetric intravascular ultrasound comparison between direct Sirolimus-Eluting stent implantation versus predilation

540

Angiographic aspects of ruptured plaque in patients with acute myocardial infarction: correlation with clinical and laboratory variables

541

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

542

Angiographic assessment of myocardial perfusion in patients with isolated coronary artery ectasia

543

Angiographic changes in saphenous vein grafts are predictors of clinical outcomes

544

Angiographic changes in vein grafts: Stable surrogate or seductive siren?

545

Angiographic Characteristics of Coronary Disease and Postresuscitation Electrocardiograms in Patients With Aborted Cardiac Arrest Outside a Hospital

546

Angiographic characteristics of infarct-related and non-infarct-related stenoses in patients in whom stable angina progressed to acute myocardial infarction, ,

547

Angiographic complications in CADASIL

548

Angiographic complications of primary angioplasty

549

Angiographic coronary artery disease associated with hypertensive heart failure and normal ejection fraction. Insights from a prospective monocenter study

550

Angiographic correlates of “spotty” coronary artery calcium detected by electron-beam computed tomography in patients with normal or near-normal coronary angiograms

551

Angiographic correlates of cardiac death and myocardial infarction complicating major nonthoracic vascular surgery

552

Angiographic Correlates of Graft Patency and Relationship to Clinical Outcomes

553

Angiographic correlates of lesion relevance and suitability for percutaneous transluminal coronary angioplasty and coronary artery bypass grafting in the bypass angioplasty revascularization investigation study (BARI)

554

Angiographic deterioration of target coronary artery narrowing as a result of percutaneous balloon angioplasty, ,

555

Angiographic embolization for arrest of bleeding after penetrating trauma to the abdomen

556

Angiographic Embolization of a Traumatic Pulmonary Pseudoaneurysm

557

Angiographic Evaluation of Myocardial Perfusion in Patients With Syndrome X

558

Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI

559

Angiographic evaluation of traumatic arterial injuries of the upper limbs: a retrospective study

560

Angiographic Evolution of Intracoronary Thrombus and Dissection Following Percutaneous Transluminal Coronary Angioplasty (The Thrombolysis and Angioplasty in Unstable Angina [TAUSA] Trial)

561

Angiographic Fate of Collateral Vessels After Surgical Revascularization of the Totally Occluded Left Anterior Descending Artery

562

Angiographic Features and Cardiovascular Risk Factors in Human Immunodeficiency Virus-Infected Patients With First-Time Acute Coronary Syndrome

563

Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angin and previous bypass surgery

564

Angiographic features, surgical management and outcomes of proximal middle cerebral artery aneurysms

565

Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry

566

Angiographic Findings and Outcome in Diabetic Patients Treated With Thrombolytic Therapy for Acute Myocardial Infarction: The GUSTO-I Experience

567

ANGIOGRAPHIC FINDINGS IN 130 PATIENTS WITH ANEURYSMAL SUBARACHNOID HEMORRHAGE

568

Angiographic findings in Buerger disease

569

Angiographic findings in monozygotic twins with coronary artery disease

570

Angiographic findings in patients undergoing catheterization for recurrent symptoms within 30 days of successful coronary intervention

571

Angiographic findings in tumoral calcinosis

572

Angiographic Findings of Patients with Blunt or Penetrating Extremity Injuries: Focus on Indications and Contraindications

573

Angiographic Findings, Time Course of Regional and Global Left Ventricular Function, and Clinical Outcome in Diabetic Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Transluminal Coronary Angioplasty

574

Angiographic Follow-up of Internal Thoracic Artery for Free Bypass Grafting

575

Angiographic follow-up results of STent versus Atherectomy Randomized Trial (START)

576

Angiographic Lesion Severity and Subsequent Myocardial Infarction

577

Angiographic Localization of Potential Culprit Coronary Arteries in Patients With Interatrial Block Following a Positive Exercise Tolerance Test

578

Angiographic methods to assess human coronary angiogenesis

579

Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction

580

Angiographic Outcomes With Early Eptifibatide Therapy in Non–ST-Segment Elevation Acute Coronary Syndrome (from the EARLY ACS Trial)

581

Angiographic Patency of the Radial Artery Conduit in Coronary Artery Bypass Grafting

582

Angiographic Pattern of Restenosis Following Implantation of Overlapping Sirolimus-Eluting (Cypher) Stents

583

Angiographic Patterns of Drug-Eluting Stent Restenosis and One-Year Outcomes After Treatment With Repeated Percutaneous Coronary Intervention

584

Angiographic patterns of restenosis after paclitaxel-eluting stent implantation

585

Angiographic perfusion score: An angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction

586

Angiographic plaque complexity: the tip of the unstable plaque iceberg

587

Angiographic Predictors and Clinical Outcome of Acute Side Branch Occlusion after Coronary Artery Stent Implantation

588

Angiographic Predictors of 6-Month Patency of Bypass Grafts Implanted to the Right Coronary Artery: A Prospective Randomized Comparison of Gastroepiploic Artery and Saphenous Vein Grafts Original Research Article

589

Angiographic predictors of adverse outcomes in the modern interventional era

590

Angiographic predictors of graft patency and disease progression after coronary artery bypass grafting with arterial and venous grafts

591

Angiographic predictors of neointimal thickening after successful coronary wall healing following percutaneous revascularization

592

Angiographic predictors of new coronary occlusions

593

Angiographic Predictors of Recurrent Stent Thrombosis (from the Outcome of PCI for Stent-ThrombosIs MultIcentre STudy [OPTIMIST])

594

Angiographic predictors of reocclusion after thrombolysis: Results from the thrombolysis in myocardial infarction (TIMI) 4 trial

595

Angiographic presence of myocardial bridge after successful percutaneous transluminal coronary angioplasty

596

Angiographic presentation of coronary artery spasm in heart transplant recipients

597

Angiographic profile in patients with congenital anomalous origin of the coronary arteries

598

Angiographic restenosis rate in patients with chronic total occlusions and subtotal stenoses after initially successful intracoronary stent placement

599

Angiographic results after the use of a sutureless aortic connector for proximal vein graft anastomoses

600

Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial)

601

Angiographic Results of the First Human Experience With the Biolimus A9 Drug-Eluting Stent for De Novo Coronary Lesions

602

Angiographic right and left ventricular function in arrhythmogenic right ventricular dysplasia

603

Angiographic severity and extent of coronary artery disease in patients with type 1 diabetes mellitus

604

Angiographic severity and extent of coronary artery disease in type 1 diabetes

605

Angiographic severity of coronary artery disease in patients with metabolic syndrome

606

Angiographic severity of coronary narrowing is a surrogate marker for the extent of coronary atherosclerosis

607

Angiographic significance of a discordant ST-segment elevation of ≥5 millimeters in patients with ventricular-paced rhythm and acute myocardial infarction

608

Angiographic Stent Thrombosis After Routine Use of Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: The Importance of Thrombus Burden Original Research Article

609

Angiographic study of aorta, coronary arteries, and left ventricular performance after neonatal arterial switch operation for simple transposition of the great arteries, ,

610

Angiographic study of Moyamoya disease and histological study in the external carotid artery system

611

Angiographic Surrogate End Points in Drug-Eluting Stent Trials: A Systematic Evaluation Based on Individual Patient Data From 11 Randomized, Controlled Trials Original Research Article

612

Angiographic variables predict increased riskfor adverse ischemic events after coronarystenting with glycoprotein IIb/IIIa inhibition: Results from the TARGET trial

613

Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation

614

Angiographic, intravascular ultrasound and functional findings early after orthotopic heart transplantation

615

Angiographic, ultrasonic, and angioscopic assessment of the coronary artery wall and lumen area configuration after directional atherectomy: The mechanism revisited

616

Angiographical and computed tomographic findings in diffuse pulmonary arteriovenous fistulas

617

Angiographical study of ramus intermedius coronary artery in Basrah

618

Angiographically assessed coronary collateral circulation increases vulnerability to myocardial ischemia during vasodilator stress testing

619

Angiographically evident atherosclerotic stenosis associated with myocardial bridging and risk factors for the artery stenosis located proximally to myocardial bridging

620

Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemi and familial combined hyperlipidemia: Correlation with high density lipoproteins

621

Angiographically silent left main disease detected by intravascular ultrasound: a marker for future adverse cardiac events

622

Angiography and arterial stimulation venous sampling in the localization of pancreatic neuroendocrine tumours

623

Angiography and interventional cardiology

624

Angiography and interventional cardiology Review Article

625

Angiography and revascularization in patients with heart failure following fibrinolytic therapy for ST-elevation acute myocardial infarction

626

Angiography of potential cardiac donors

627

Angiography versus intravascular ultrasound assessment of coronary stent placement: observations from the AVID study

628

Angiography; an Inducer of TGF-Β during Early Atherosclerosis

629

Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients

630

Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients

631

Angioid streaks and other ocular complications of Pagetʹs disease of bone

632

Angioimmunoblastic lymphadenopathy-like T-cell lymphoma A case report and immunologic study

633

Angiokeratoma corporis diffusum without systemic features in a young Kashmiri female: a rare occurrence

634

Angioleiomyoma in the tonsil: an uncommon tumour in a rare site

635

Angioleiomyoma of the diaphragm

636

Angioleiomyoma of the Hand: A Case Series and Review of the Literature

637

Angioleiomyoma: a benign tumor with karyotypic aberrations

638

Angiolipoma of the breast with microcalcification: Mammographic, sonographic, and histologic appearances

639

Angiolymphoid hyperplasia with eosinophilia

640

Angiolymphoid hyperplasia with eosinophilia

641

ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA – A RARE ENTITY

642

Angioma serpiginosum successfully treated by a single session of intense pulsed light therapy

643

Angiomagnetic resonance imaging of iliofemorocaval venous thrombosis

644

Angiomatoid fibrous histiocytoma in mediastinum

645

Angiomatoid Fibrous Histiocytoma, A Great Mimicker – A Short Series of 3 Cases with EWSR1 Fusion

646

Angiomyofibroblastoma mimicking an inguinal hernia: a challenging diagnosis in a male patient

647

Angiomyofibroblastoma of the Vaginal Portion

648

Angiomyofibroblastoma of the Vulva

649

Angiomyogenesis using liposome based vascular endothelial growth factor-165 transfection with skeletal myoblast for cardiac repair

650

Angiomyolipoma and Malignant PEComa: Discussion of TwoRare Adrenal Tumors

651

Angiomyolipoma of the Adrenal Gland: A Case Report

652

Angiomyoma of the Hard Palate

653

Angiomyxolipoma; Report of a new case in subcutaneous tissue and review of the literature

654

Angiomyxoma Presenting as an Unusual Vaginal Mass

655

Angioneogenesis as a possible elusive triggering factor in rheumatoid arthritis

656

Angioneogenesis in rheumatoid arthritis

657

Angioneogenesis in rheumatoid arthritis

658

ANGIOPEPTIDES: NOVEL PEPTIDES THAT INDUCE ANGIOGENESIS

659

ANGIOPLASTY AND STENTING OF BASILAR ARTERY:SHORT-TERM OUTCOMES

660

ANGIOPLASTY AND STENTING OF BASILAR ARTERY:SHORT-TERM OUTCOMES

661

Angioplasty and stenting of the distal coronary anastomosis for graft failure immediately after coronary artery bypass grafting

662

Angioplasty for acute myocardial infarction in community hospital without surgical back-up: Response to Wharton and Angelini publications “should guidelines be changed?: Not whether but when”

663

Angioplasty for coarctation in different aged patients

664

Angioplasty for intermittent claudication

665

Angioplasty for lower-limb ischaemia: time for randomised controlled trials

666

Angioplasty for the late stent thrombosis, the new technical challenge: A single centre experience

667

Angioplasty Guidewire Velocity: A New Simple Method to Calculate Absolute Coronary Blood Velocity and Flow

668

Angioplasty in the stent era: results of a consecutive series of patients undergoing coronary angioplasty without surgical backup

669

Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA

670

Angioplasty of a left anterior descending artery originating from the right sinus of Valsalva (discussion in decision making)

671

Angioplasty of atherosclerotic and fibromuscular renal artery stenosis: time course and predicting factors of the effects on renal function

672

Angioplasty of complex lesions in ischemic rest angina: Results of the Thrombolysis and Angioplasty in Unstable Angin (TAUSA) Trial

673

Angioplasty of the internal thoracic artery bypass-graft an alternative to reoperation

674

Angioplasty or Surgery for Multivessel Coronary Artery Disease: Comparison of Eligible Registry and Randomized Patients in the EAST Trial and Influence of Treatment Selection on Outcomes

675

Angioplasty through a stent side door

676

Angioplasty versus bypass surgery

677

Angioplasty versus bypass surgery

678

Angioplasty versus bypass surgery

679

Angioplasty versus intravenous thrombolysis for acute myocardial infarction

680

Angioplasty vs medical therapy in the treatment of unilateral atherosclerotic renal artery stenosis: A prospective randomized open blinded-endpoint trial

681

Angioplasty, inflammation, and antiplatelet agents

682

Angioplasty-induced superoxide anions and neointimal hyperplasia in the rabbit carotid artery: suppression by the isoflavone trans-tetrahydrodaidzein

683

Angiopoietin 2 Level in Type 2 Diabetic Patients with Cardiovascular Complications

684

Angiopoietin like protein 3 (Angptl3), fatty acid binding protein 4 (FABP4) and homeostasis model assessment of insulin resistance (HOMA-IR) among Indonesian obese non diabetic males

685

ANGIOPOIETIN-1 AND -2 MEDIATE PROINFLAMMATORY RESPONSES IN HUMAN ENDOTHELIAL CELLS

686

Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis

687

Angiopoietin-1 supports induction of hematopoietic activity in human CD34− bone marrow cells

688

Angiopoietin2 enhances doxorubin resistance in HepG2 cells by upregulating survivin and Ref-1 via MSK1 activation

689

ANGIOPOIETIN-2 IS AN AUTOCRINE REGULATOR OF ENDOTHELIAL CELL RESPONSIVENESS AND VASCULAR HOMEOSTASIS

690

Angiopoietin-like 4 Protein Elevates the Prosurvival Intracellular O2−:H2O2 Ratio and Confers Anoikis Resistance to Tumors

691

Angiopoietin-like protein 2 in psoriasis: a new linkage with metabolic syndrome

692

Angiopoietin-like protein 8 (betatrophin) may inhibit hepatocellular carcinoma through suppressing of the Wnt signaling pathway

693

Angiopoietin-like proteins: Another player in the metabolic field

694

Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy

695

Angiopoietin-like-4 is a potential angiogenic mediator in arthritis

696

Angiopoietins in angiogenesis

697

Angiopoietins in malignancy

698

Angiopoietins: a link between angiogenesis and inflammation

699

Angiosarcoma after conservative treatment and radiation therapy for adenocarcinoma of the breast

700

Angiosarcoma as a sequela of breast cancer treatment with lumpectomy and radiotherapy

701

Angiosarcoma at Dialysis Fistula Site in a Patient on Continuous Ambulatory Peritoneal Dialysis

702

Angiosarcoma in the right atria demonstrated by fusion images of multislice computed tomography and positron emission tomography using F-18 Fluoro-Deoxyglucose

703

Angiosarcoma of Kidney A Case Report and Review of Literature

704

Angiosarcoma of the breast after quadrantectomy and postoperative radiotherapy for carcinoma

705

Angiosarcoma of the breast: a 30 year perspective with an optimistic outlook

706

Angiosarcoma of the chest wall

707

Angiosarcoma of the Liver Presenting with Esophageal Bleeding and Arterio-portal Shunts

708

Angiosarcoma of the liver: MR imaging pre- and post-chemotherapy

709

Angiosarcoma of the pericardium presenting as hemorrhagic pleuropericarditis, cardiac tamponade, and thromboembolic phenomena

710

Angiosarcoma of the Right Atrium with Extension to SVC and IVC Presenting with Complete Heart Block and Significant Pericardial Effusion

711

Angiosarcoma of the right atrium: A diagnostic dilemma

712

Angiosarcoma of the small intestine

713

Angiosarcoma: complication of breast conservation treatment

714

Angiosarcome mammaire primitif : à propos de deux cas

715

Angioscopic and Virtual Histology Intravascular Ultrasound Characteristics of Culprit Lesion Morphology Underlying Coronary Artery Thrombosis

716

Angioscopic Assessment of Coronary Lesions Underlying Thrombus

717

Angioscopic characteristics of coronary narrowing in patients with recurrent myocardial ischemia after myocardial infarction

718

Angioscopic Comparison of Neointimal Coverage Between Zotarolimus- and Sirolimus-Eluting Stents

719

Angioscopic Coronary Macromorphology After Thrombolysis in Acute Myocardial Infarction

720

Angioscopic detection of residual pulmonary thrombi in the differential diagnosis of pulmonary embolism

721

Angioscopic evaluation of angiographically complex coronary lesions,

722

Angioscopic evaluation of atherosclerotic plaques: Validation by histomorphologic analysis and association with stable and unstable coronary syndromes

723

Angioscopic evaluation of neointima coverage: Sirolimus drug-eluting stent versus bare metal stent

724

Angioscopic Evaluation of Rotational Atherectomy Followed by Additional Balloon Angioplasty Versus Balloon Angioplasty Alone in Coronary Artery Disease: Prospective, Randomized Study

725

Angioscopic findings during coronary angioplasty of coronary occlusions

726

Angioscopic findings of delayed healing at sites of sirolimus-eluting stent overlap after 21-month implantation

727

Angioscopic follow-up study of coronary ruptured plaques in nonculprit lesions Original Research Article

728

Angioscopic identification of coronary thrombus in patients with postinfarction angina

729

Angioscopic versus angiographic detection of thrombus during coronary interventional procedures

730

Angioscopy of Culprit Coronary Lesions in Unstable Angina Pectoris and Correlation of Clinical Presentation With Plaque Morphology

731

Angioscopy variables predictive of early angiographic outcome after excimer laser-assisted coronary angioplasty

732

Angioseal use after antegrade femoral arteriotomy in patients undergoing percutaneous revascularization for critical limb ischemia: A case series

733

Angiosome-targeted isolated tibial angioplasty for healing of ischemic foot ulcer: a retrospective study

734

Angiosperm DNA contamination by endophytic fungi: Detection and methods of avoidance

735

Angiosperms (seagrass) within the EU water framework directive: A UK perspective

736

Angiostrongylus eosinophilic meningitis in Egypt

737

Angiostrongylus vasorum from South America and Europe represent distinct lineages

738

Angiotenin II and vacular endothelial growth factor in the vitreou fluid of patient with diabetic macular edema and other retinal diorder

739

Angiotensin (1–7) and Apelin co-therapy: New strategy for heart failure treatment of rats

740

Angiotensin (1-7) Inhibits Ang II-mediated ERK1/2 Activation by Stimulating MKP-1 Activation in Vascular Smooth Muscle Cells

741

Angiotensin 1-7 Administration Increases Renal Blood Flow in the Absence of Bradykinin B2 Receptor in Ovariectomized Estradiol Treated Rats: The Role of Mas Receptor

742

Angiotensin 1-7 Receptor and Angiotensin II Receptor 2 Blockades Prevent the Increased Serum and Kidney Nitric Oxide Levels in Response to Angiotensin II Administration: Gender-Related Difference

743

Angiotensin 2 type 1 receptor blocker attenuates atrial structural remodeling in spontaneously hypertensive rats: Role of the suppression of atrial oxidative stress

744

Angiotensin and asymmetric fetal growth

745

Angiotensin and vascular fibrinolytic balance

746

Angiotensin antagonists and renal ischemia/reperfusion: Possible modulation by L-carnitine

747

Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade

748

Angiotensin blockade for hypertension: a promise fulfilled

749

Angiotensin Blockade Inhibits Increased JNKs, AP-1 and NF- κ B DNA-binding Activities in Myocardial Infarcted Rats

750

Angiotensin Blockade Inhibits SIF DNA Binding Activities via STAT3 after Myocardial Infarction

751

Angiotensin converting enzyme (ACE D/I) polymorphism and its relation to liver fibrosis progression in Egyptian patients with chronic hepatitis C virus infection

752

Angiotensin Converting Enzyme (ACE) Activity Levels in Insulin-independent Diabetes Mellitus and Effect of ACE levels on Diabetic Patients with Nephropathy

753

Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease

754

Angiotensin converting enzyme (ACE) gene expression in experimentally induced liver cirrhosis in rats

755

Angiotensin converting enzyme (ACE) inhibitory, antihypertensive and antihyperlipidaemic activities of protein hydrolysates from Rhopilema esculentum

756

Angiotensin Converting Enzyme and Myofibroblasts during Tissue Repair in the Rat Heart

757

Angiotensin converting enzyme gene — a candidate gene for addiction to smoking?

758

Angiotensin Converting Enzyme Gene I/D Polymorphism in Pakistani Rheumatic Heart Disease Patients and Healthy Controls

759

Angiotensin converting enzyme gene insertion/deletion polymorphism, angiotensinogen gene polymorphisms, family history of hypertension, and childhood blood pressure

760

Angiotensin Converting Enzyme Gene Insertion/Deletion Variant and Familial Mediterranean Fever-related Amyloidosis

761

Angiotensin converting enzyme gene polymorphism and activity in Turkish patients with essential hypertension

762

Angiotensin converting enzyme gene polymorphism and the course of angiographically defined coronary artery disease

763

Angiotensin Converting Enzyme Gene Polymorphism in Aizheimers Disease

764

Angiotensin Converting Enzyme Gene Polymorphism in Essential Hypertension Based on Ambulatory Blood Pressure Monitoring

765

Angiotensin Converting Enzyme Gene Polymorphism in Iranian Patients with Type 2 Diabetes

766

Angiotensin Converting Enzyme Gene Polymorphism Is Not Related to Essential Hypertension in a Greek Population

767

Angiotensin Converting Enzyme I/D Polymorphism and Chronic Hepatitis C Virus Infection

768

Angiotensin Converting Enzyme I/D Polymorphism in Egyptian Patients with Type 2 Diabetes Mellitus

769

Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical NG, NG-dimethylarginine in human essential hypertension

770

Angiotensin converting enzyme inhibition by captopril influences cardiac work in healthy hearts

771

Angiotensin Converting Enzyme Inhibition Corrects Na+/H+ Exchanger Overactivity in Essential Hypertension

772

Angiotensin converting enzyme inhibition, with quinapril, improves endothelial vasomotor dysfunction in patients with coronary artery disease: The TREND study (trial on reversing endothelial dysfunction)

773

Angiotensin converting enzyme inhibitor as an additive treatment after successful balloon dilation of a critical pulmonary valve stenosis

774

Angiotensin converting enzyme inhibitor captopril does not improve exercise tolerance or reduce exercise induced myocardial ischemi in patients with angin pectoris

775

Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese

776

Angiotensin Converting Enzyme Inhibitor-related Angioedema: A Case of an Unexpected Death

777

ANGIOTENSIN CONVERTING ENZYME- INHIBITORS ASSOCIATED COUGH: A PROSPECTIVE EVALUATION IN HYPERTENSIVES

778

Angiotensin Converting Enzyme Inhibitors, A Risk Factor of Poor Outcome in Diabetic Patients with COVID-19 Infection

779

Angiotensin Converting Enzyme Insertion/Deletion Gene Polymorphism: An Observational Study among Diabetic Hypertensive Subjects in Malaysia

780

Angiotensin- Converting Enzyme Insertion/Deletion Polymorphism and Its Association with Coronary Artery Disease in an Iranian Population

781

Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimerʹs disease and longevity

782

Angiotensin I converting enzyme (ACE) gene polymorphism and essential hypertension in Japan: Ethnic difference of ACE genotype

783

Angiotensin I converting enzyme (ACE) inhibitory peptide derived from the sauce of fermented blue mussel, Mytilus edulis

784

Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with angina pectoris

785

Angiotensin I Converting Enzyme Gene Polymorphism in Chinese Patients With Hypertension

786

Angiotensin I Converting Enzyme Inhibitory Activities of Hydroalcoholic Extracts of Nardostachys jatamansi, Prangos ferulacea and Marrubium vulgare

787

Angiotensin I Modulates Ca-transport Systems in the Rat Heart Through Angiotensin II

788

Angiotensin I retention behavior on Butyl-Sepharose under linear loading chromatographic conditions

789

Angiotensin I-Converting Enzyme (ACE) Gene Polymorphism in Relation to Physical Performance, Cognition and Survival—A Follow-up Study of Elderly Danish Twins

790

Angiotensin I–converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene

791

Angiotensin I-converting enzyme (ACE) inhibitory activities of sardinelle (Sardinella aurita) by-products protein hydrolysates obtained by treatment with microbial and visceral fish serine proteases

792

Angiotensin I-converting enzyme (ACE) inhibitory peptides derived from arachin by simulated gastric digestion

793

Angiotensin I–converting enzyme and plasminogen activator inhibitor-1 gene variants: risk of mortality and fatal cardiovascular disease in an elderly population-based cohort

794

Angiotensin I–converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women

795

Angiotensin I-Converting Enzyme Gene Polymorphism and Acute Response to Captopril in Essential Hypertension

796

Angiotensin I-converting enzyme gene polymorphism in a low-risk European population for coronary artery disease Original Research Article

797

Angiotensin I-converting enzyme inhibitor derived from soy protein hydrolysate and produced by using membrane reactor

798

Angiotensin I-converting enzyme inhibitory compounds in white and red wines

799

Angiotensin I-converting enzyme inhibitory oligo-tyrosine peptides synthesized by α-chymotrypsin

800

Angiotensin I-converting enzyme inhibitory peptide from yellowfin sole (Limanda aspera) frame protein and its antihypertensive effect in spontaneously hypertensive rats

801

Angiotensin I-converting enzyme inhibitory peptides in douchi, a Chinese traditional fermented soybean product

802

Angiotensin I-converting enzyme inhibitory properties of lentil protein hydrolysates: Determination of the kinetics of inhibition

803

Angiotensin I–converting enzyme insertion/insertion genotype as a genetic risk factor for cardiovascular disease

804

Angiotensin I-converting enzyme-inhibitory peptide fractions from albumin 1 and globulin as obtained of amaranth grain

805

Angiotensin II (Ang II) stimulates sympathetic nerve (SNS) activity through activation of oxidative stress

806

Angiotensin II (AngII) activates nuclear factor-κB via AT1 and AT2 receptors in the kidney

807

Angiotensin II activates intermediate-conductance Ca2+-activated K+ channels in arterial smooth muscle cells

808

Angiotensin II Activates Stat5 Through Jak2 Kinase in Cardiac Myocytes

809

Angiotensin II activation of Src mediates ERK stimulation in human vascular smooth muscle cells

810

Angiotensin II and atherosclerosis

811

Angiotensin II and cardiomyocyte apoptosis in the SHR

812

Angiotensin II and Intracellular Calcium of Adult Cardiac Fibroblasts

813

Angiotensin II and the pathophysiology of cardiovascular remodeling

814

Angiotensin II and trials of cardiovascular outcomes

815

Angiotensin II antagonists block ethanol effects on the aerial righting reflex

816

Angiotensin II antagonists demonstrate greater long-term persistence versus other antihypertensive medications

817

Angiotensin II antagonists for hypertension: are there differences in efficacy?

818

Angiotensin II antagonists for hypertension: there are differences in efficacy

819

Angiotensin II antagonists for hypertension: there are differences in efficacy: The reply

820

Angiotensin II AT1 Receptor Blockade Improves Renal Perfusion in Hypercholesterolemia

821

Angiotensin II AT1 receptor blockade normalizes CD11b+ monocyte production in bone marrow of hypercholesterolemic monkeys

822

Angiotensin II AT1 receptor gene polymorphism and microalbuminuria in essential hypertension

823

Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis

824

Angiotensin II Differentially Induces Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Production and Disturbs MMP/TIMP Balance

825

Angiotensin II directly inhibits protein synthesis in murine myotubes

826

Angiotensin II Elevates Nitric Oxide Synthase 3 Expression and Nitric Oxide Production Via a Mitogen-Activated Protein Kinase Cascade in Ovine Fetoplacental Artery Endothelial Cells

827

Angiotensin II enhances cardiac Na+/Ca2+ exchanger current via an autocrine release of endothelin

828

Angiotensin II Enhances the Expression of Giα in A10 Cells (Smooth Muscle): Relationship with Adenylyl Cyclase Activity

829

Angiotensin II increases expression and secretion of cathepsin F in cultured human monocyte-derived macrophages: An angiotensin II type 2 receptor-mediated effect

830

Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: A mechanism by which angiotensin II antagonizes cGMP signaling

831

Angiotensin II increases the expression of lectin-like oxidized low-density lipoprotein receptor-1 in human vascular smooth muscle cells via a lipoxygenase-dependent pathway

832

Angiotensin II increases the release of endothelin-I from human cultured endothelial cells but does not regulate its circulating levels

833

Angiotensin II induced hyperplasia and hypertrophy in human vascular smooth muscle cells are mediated via AT1 receptors

834

Angiotensin II Induces Apoptosis of Adult Ventricular MyocytesIn Vitro

835

Angiotensin II induces DNA injury in human umbilical artery smooth muscle cells via a mechanism which involves hydrogen peroxide

836

Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice

837

Angiotensin II induces interleukin-6 synthesis in osteoblasts through ERK1/2 pathway via AT1 receptor

838

Angiotensin II induces mitochondrial dysfunction and promotes apoptosis via JNK signalling pathway in primary mouse calvaria osteoblast

839

Angiotensin II Induces Nuclear Factor- κ B Activation in Cultured Neonatal Rat Cardiomyocytes Through Protein Kinase C Signaling Pathway

840

Angiotensin II induces phosphorylation of glucose-regulated protein-75 in WB rat liver cells

841

Angiotensin II infusion induces site-specific intra-laminar hemorrhage in macrophage colony-stimulating factor-deficient mice

842

Angiotensin II inhibition and prevention of atrial fibrillation and stroke

843

Angiotensin II inhibition during myocardial ischemia–reperfusion in dogs: effects on leukocyte infiltration, nitric oxide synthase isoenzymes activity and left ventricular ejection fraction

844

Angiotensin II inhibition of Ca2+ currents is independent of ATR1 angiotensin II receptor activation in rat adult vagal afferent neurons

845

Angiotensin II Inhibits Insulin-Induced egr-1 Expression in Mesangial Cells

846

Angiotensin II inhibits the forearm vascular response to increased arterial pressure in humans

847

Angiotensin II Mechanisms in Ischemic Heart Disease: Pathophysiology and Survival

848

Angiotensin II mechanisms in the renal responses to hypertension and diabetes mellitus.

849

Angiotensin II Modulates ANP-R2/ANP-C Receptor-mediated Inhibition of Adenylyl Cyclase in Vascular Smooth Muscle Cells: Role of Protein Kinase C

850

Angiotensin II Plays a Critical Role in Alcohol-Induced Cardiac Nitrative Damage, Cell Death, Remodeling, and Cardiomyopathy in a Protein Kinase C/Nicotinamide Adenine Dinucleotide Phosphate Oxidase–Dependent Manner

851

Angiotensin II Plays an Important Role in Maintaining Blood Pressure in Postmenopausal Women Receiving Hormone Replacement Therapy

852

Angiotensin II Potentiates DNA Synthesis in AT-1 Transformed Cardiomyocytes

853

Angiotensin II promotes ICAM-1 expression in vitro and soluble ICAM-1 secretion in vivo

854

Angiotensin II receptor antagonism does not prevent tolerance to continuous transdermal nitroglycerin

855

Angiotensin II Receptor Antagonist Blocks the Expression of Connexin43 Induced by Cyclical Mechanical Stretch in Cultured Neonatal Rat Cardiac Myocytes

856

Angiotensin II receptor antagonists Review Article

857

Angiotensin II receptor blockade and end-organ protection

858

Angiotensin II receptor blockade by losartan reduces the incidence of heart failure after an MI in rat

859

Angiotensin II receptor blockade does not improve left ventricular function andremodeling in subacute mitral regurgitation in the dog

860

Angiotensin II receptor blockade in diabetic nephropathy

861

Angiotensin II receptor blockade in diabetic nephropathy

862

Angiotensin II receptor blockade reduces expression of basic fibroblast growth factor mRNA in the balloon injured rat carotid artery. Quantification by competitive polymerase chain reaction

863

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End point reduction in hypertension (LIFE) study Original Research Article

864

ANGIOTENSIN II RECEPTOR BLOCKER VALSARTAN ENHANCES GLUCOSE-INDUCED INSULIN SECRETION

865

Angiotensin II receptor blockers and angiotensin converting enzyme inhibitors: implication of radical scavenging and transition metal chelation in inhibition of advanced glycation end product formation

866

Angiotensin II Receptor Blockers and Risk of Cancer in Patients With Systemic Hypertension

867

Angiotensin II Receptor Blockers Downsize Adipocytes in Spontaneously Type 2 Diabetic Rats With Visceral Fat Obesity

868

Angiotensin II receptor blockers: review of the binding characteristics

869

Angiotensin II Receptor Subtypes and Biological Responses in the Rat Heart

870

Angiotensin II Receptor Type 1 mRNA is Upregulated in Atria of Patients with End-stage Heart Failure

871

Angiotensin II receptors from peritransplantation through first-year post-transplantation and the risk of transplant coronary artery disease Original Research Article

872

Angiotensin II reduces alcohol intake and choice in water- or food-restricted rats

873

Angiotensin II regulates AT2 subtype receptor promoter activity and expression in rat primary endothelial cell

874

Angiotensin II regulates the cell cycle of vascular smooth muscle cells from SHR

875

Angiotensin II Release From Rabbit Intrarenal Arteries: A Critical Assessment

876

Angiotensin II signals mechanical stretch-induced cardiac matrix metalloproteinase expression via JAK-STAT pathway

877

Angiotensin II Stimulated Expression of Transforming Growth Factor-β1in Cardiac Fibroblasts and Myofibroblasts

878

Angiotensin II stimulates cardiac chloride/bicarbonate exchange activity by phosphorylation of serine 67 of AE3

879

Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure

880

Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure

881

Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins Original Research Article

882

Angiotensin II stimulates phosphorylation and nuclear accumulation of R-Smad 2 in cultured cardiac fibroblasts: T-type Ca channel blockade in vascular smooth muscle cells causes G1S cell cycle arrest

883

Angiotensin II stimulates synthesis of vascular smooth muscle cell proteoglycans with enhanced low density lipoprotein binding properties

884

Angiotensin II subtype-1 receptor antagonists improve hemodynamic and renal changes without affecting glucose metabolisms in genetic rat model of non–insulin-dependent diabetes mellitus

885

Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide

886

Angiotensin II type 1 receptor (A1166C) gene polymorphism in Egyptian adult hemodialysis patients

887

Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure

888

Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer

889

Angiotensin II Type 1 Receptor Blockade Abolishes Specific KATPChannel Gene Expression in Rats with Myocardial Ischemia

890

Angiotensin II type 1 receptor blockade improves cardiac expression of hsp72 and tolerance against ischemia/reperfusion injury in insulin resistance rat

891

Angiotensin II type 1 receptor blocker losartan attenuates locomotor, anxiety-like behavior, and passive avoidance learning deficits in a sub-chronic stress model

892

Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice

893

Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patients: a randomized, double-blind, placebo-controlled study

894

Angiotensin II Type 1 Receptor Gene A1166C Polymorphism Was Not Associated With Acute Coronary Syndrome in an Iranian Population

895

Angiotensin II type 1 receptor gene polymorphism and mitral valve prolapse syndrome

896

Angiotensin II Type 1 Receptor Gene Polymorphism Is Associated With Increase of Left Ventricular Mass But Not With Hypertension

897

Angiotensin II type 1 receptor polymorphisms in the cardiovascular health study: relation to blood pressure, ethnicity, and cardiovascular events

898

Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation

899

Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists

900

Angiotensin II type-I receptor antagonists in the treatment of heart failure

901

Angiotensin II upregulates transforming growth factor-β type I receptor on rat vascular smooth muscle cells

902

Angiotensin II, oxidative stress, and extracellular matrix degradation during transition to LV failure in rats with hypertension

903

Angiotensin II, Transforming Growth Factor-β1and Repair in the Infarcted Heart

904

Angiotensin II, VEGF, and diabetic retinopathy

905

Angiotensin II, VEGF, and diabetic retinopathy

906

Angiotensin II, VEGF, and diabetic retinopathy

907

Angiotensin II-dependent growth of vascular smooth muscle cells requires transactivation of the epidermal growth factor receptor via a cytosolic phospholipase A2-mediated release of arachidonic acid

908

Angiotensin II-induced C-reactive protein generation: Inflammatory role of vascular smooth muscle cells in atherosclerosis

909

Angiotensin II-induced ionic currents and signalling pathways in submandibular ganglion neurons

910

Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats

911

Angiotensin II-Mediated apoptosis and P53 expression in human cardiomyocytes

912

Angiotensin II-mediated Growth and Antigrowth Effects in Cultured Neonatal Rat Cardiac Myocytes and Fibroblasts

913

Angiotensin IV-evoked vasoprotection is conserved in advanced atheroma

914

Angiotensin receptor antagonists

915

Angiotensin receptor antagonists: focus on losartan

916

Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome

917

Angiotensin receptor blockade improves myocardial beta-adrenergic receptor signaling in postinfarction left ventricular remodeling: A possible link between beta-adrenergic receptor kinase-1 and protein kinase C epsilon isoform Original Research Article

918

Angiotensin Receptor Blocker and N-Acetyl Cysteine for Reduction of Proteinuria in Patients With Type 2 Diabetes Mellitus

919

Angiotensin Receptor Blockers – finally the evidence is coming in: IDNT and RENAAL

920

Angiotensin Receptor Blockers and Cardiovascular Protection: Are We ONTARGET?

921

Angiotensin receptor blockers and diuretics as combination therapy: clinical implications

922

Angiotensin Receptor Blockers and Magnesium Status in Essential Hypertension

923

Angiotensin receptor blockers in heart failure: A work in progress

924

Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials

925

Angiotensin receptor blockers in the prevention of atrial fibrillation recurrence: Need for a definitive trial

926

Angiotensin receptor blockers in the prevention of atrial fibrillation recurrence: Need for a definitive trial

927

Angiotensin Receptor Blockers: Current Status and Future Prospects

928

Angiotensin receptor blockers: how important is selectivity?

929

Angiotensin receptor blockers—finally the evidence is coming in: IDNT and RENAAL

930

Angiotensin receptor neprilysin inhibitor in inotrope dependent heart failure patients: A case series

931

Angiotensin Receptor-1 Blocker Inhibits Atherosclerotic Changes and Endothelial Disruption of the Aortic Valve in Hypercholesterolemic Rabbits Original Research Article

932

Angiotensin Receptors in Cardiac and Renal Hypertrophy in Rats

933

Angiotensin receptors: history and mysteries

934

Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis

935

Angiotensin Type 2 Receptor Gene Polymorphisms and Susceptibility to Preeclampsia

936

Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons

937

Angiotensin-(1–7) and vasopeptidase inhibition

938

Angiotensin-(1–7) central administration induces anxiolytic-like effects in elevated plus maze and decreased oxidative stress in the amygdala

939

ANGIOTENSIN, BRADYKININ AND CONVERTING ENZYME IN IMPOSED AND PHYSIOLOGICAL FLOW-RELATED ARTERIAL REMODELING.

940

Angiotensin, fibrinolysis, and vascular homeostasis

941

Angiotensin-Converting Enzyme (ACE) Inhibitor Angioedema: The Silent Epidemic

942

Angiotensin-converting enzyme (ACE) inhibitors revert abnormal right ventricular filling in patients with restrictive left ventricular disease

943

Angiotensin-converting enzyme (ACE), angiotensinogen (AGT), and angiotensin II type 1 receptor (AT1R) gene polymorphisms in generalized aggressive periodontitis

944

Angiotensin-converting enzyme (CD143) is abundantly expressed by dendritic cells and discriminates human monocyte-derived dendritic cells from acute myeloid leukemia-derived dendritic cells

945

angiotensin-converting enzyme 2 (ace2) gene polymorphism in patients with type 2 diabetes (t2dm) in thi-qar, iraq

946

Angiotensin-converting enzyme 2 acts as a potential molecular target for pancreatic cancer therapy

947

Angiotensin-converting enzyme activity and contractile effects of angiotensin I and II in human uteroplacental arteries

948

Angiotensin-converting enzyme and apolipoprotein B polymorphisms in coronary artery disease

949

Angiotensin-Converting Enzyme and Heart Chymase gene Polymorphisms in Hypertrophic Cardiomyopathy

950

Angiotensin-converting enzyme and p22phox polymorphisms and the risk of coronary heart disease in a low-risk Spanish population

951

Angiotensin-converting Enzyme and Renin Inhibition Activities, Antioxidant Properties, Phenolic and Flavonoid Contents of Cuphea ignea A. DC.

952

Angiotensin-Converting Enzyme Assay Optimization:Influence of Various Buffers and Their Concentrations

953

Angiotensin-converting enzyme gene deletion polymorphism modulation of onset of symptoms and survival rate of patients with heart failure

954

Angiotensin-converting enzyme gene I/D polymorphism and carotid artery disease in renovascular hypertension

955

Angiotensin-converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: Identifying the guideposts for navigating the genetics landscape

956

Angiotensin-converting enzyme gene polymorphism and common carotid stiffness: The Rotterdam study

957

Angiotensin-converting enzyme gene polymorphism in a cohort of coronary angiography patients

958

Angiotensin-converting enzyme gene polymorphism in Japanese patients with hypertrophic cardiomyopathy

959

Angiotensin-converting enzyme gene polymorphism in preeclampsia and normal pregnancy

960

Angiotensin-Converting Enzyme Gene Polymorphism in Systemic Hypertension

961

Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis

962

Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction

963

Angiotensin-converting enzyme genetic variants do not influence response to risperidone in autistic children

964

Angiotensin-converting enzyme genotype affects skeletal muscle strength in elite athletes

965

Angiotensin-Converting Enzyme Genotype Predicts Cardiac and Autonomic Responses to Prolonged Exercise Original Research Article

966

Angiotensin-Converting Enzyme Genotypes and Risk for Myocardial Infarction in Women

967

Angiotensin-Converting Enzyme I/D Polymorphism in Behçet’s Disease

968

Angiotensin-converting enzyme inhibition after myocardial infarction: the trandolapril cardiac evaluation study

969

Angiotensin-Converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats

970

Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet

971

Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patients

972

Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium

973

Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation Original Research Article

974

Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function: Ischemia Management with Accupril post–bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the othe

975

Angiotensin-converting enzyme inhibition is associated with reduced troponin release in non–ST-elevation acute coronary syndromes

976

Angiotensin-converting enzyme inhibition limits dysfunction in adjacent noninfarcted regions during left ventricular remodeling

977

Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction

978

Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane

979

Angiotensin-converting enzyme inhibition to enhance vascular health—clinical and research models

980

Angiotensin-converting enzyme inhibition, autonomic activity, and hemodynamics in patients with heart failure who perform isometric exercise

981

Angiotensin-Converting Enzyme Inhibitor as a Marker, Not a Risk Factor, for Poor Prognosis

982

Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction Original Research Article

983

Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure,

984

Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure

985

Angiotensin-converting enzyme inhibitor dosing in heart failure: What is optimal?

986

Angiotensin-converting enzyme inhibitor for epirubicin-induced dilated cardiomyopathy

987

Angiotensin-converting enzyme inhibitor meta-analysis provides misleading conclusion

988

Angiotensin-Converting Enzyme Inhibitor Prevents Plasminogen Activator Inhibitor-1 Expression in a Rat Model with Cardiovascular Remodeling Induced by Chronic Inhibition of Nitric Oxide Synthesis

989

Angiotensin-Converting Enzyme Inhibitor Therapy Affects Left Ventricular Mass in Patients With Ejection Fraction >40% After Acute Myocardial Infarction

990

Angiotensin-Converting Enzyme Inhibitor Therapy at the Time of Coronary Artery Bypass Surgery: When a Friend Turns Mean-Spirited

991

Angiotensin-converting enzyme inhibitor treatment after myocardial infarction: A selective approach for maximum benefit

992

Angiotensin-converting enzyme inhibitor use in survivors of acute myocardial infarction

993

Angiotensin-Converting Enzyme Inhibitor, Angiotensin Receptor Blocker Use, and Mortality in Patients With Chronic Kidney Disease

994

Angiotensin-converting enzyme inhibitors after myocardial infarction: Indications and timing

995

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease

996

Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study

997

Angiotensin-converting enzyme inhibitors and myocardial infarction: A class effect?

998

Angiotensin-Converting Enzyme Inhibitors and Outcome Among Patients With Heart Failure and Renal Insufficiency: Need for a Prospective Study

999

Angiotensin-converting enzyme inhibitors and β-blockers in long-term treatment of dilated cardiomyopathy

1000

Angiotensin-converting enzyme inhibitors as a cause of unilateral tongue angioedema in a 68-year-old woman

بازگشت